Mock Recruitment for the Study of Antimalarials in an Incomplete Lupus Erythematosus Trial.
Edward M BehrensBenjamin F ChongJudith A JamesCristina ArriensMariko IshimoriDaniel J WallaceDuanping LiaoNancy J OlsenPublished in: Arthritis care & research (2020)
The mock recruitment suggests that the trial will be attractive to suitable patients. The concerns raised support other data indicating that provision of information is crucial to achieving enrollment goals. Mock recruitment of potential investigators should be considered also to address referral concerns.
Keyphrases
- end stage renal disease
- study protocol
- phase iii
- clinical trial
- chronic kidney disease
- ejection fraction
- newly diagnosed
- primary care
- prognostic factors
- peritoneal dialysis
- randomized controlled trial
- healthcare
- rheumatoid arthritis
- machine learning
- patient reported outcomes
- health information
- risk assessment
- human health
- data analysis